title: Effects of streptozotocin-diabetes on the hippocampal NMDA receptor complex in rats.
abstract: In animal models of diabetes mellitus, such as the streptozotocin-diabetic rat (STZ-rat), spatial learning impairments develop in parallel with a reduced expression of long-term potentiation (LTP) and enhanced expression of long-term depression (LTD) in the hippocampus. This study examined the time course of the effects of STZ-diabetes and insulin treatment on the hippocampal post-synaptic glutamate N-methyl-D-aspartate (NMDA) receptor complex and other key proteins regulating hippocampal synaptic transmission in the post-synaptic density (PSD) fraction. In addition, the functional properties of the NMDA-receptor complex were examined. One month of STZ-diabetes did not affect the NMDA receptor complex. In contrast, 4 months after induction of diabetes NR2B subunit immunoreactivity, CaMKII and Tyr-dependent phosphorylation of the NR2A/B subunits of the NMDA receptor were reduced and alphaCaMKII autophosphorylation and its association to the NMDA receptor complex were impaired in STZ-rats compared with age-matched controls. Likewise, NMDA currents in hippocampal pyramidal neurones measured by intracellular recording were reduced in STZ-rats. Insulin treatment prevented the reduction in kinase activities, NR2B expression levels, CaMKII-NMDA receptor association and NMDA currents. These findings strengthen the hypothesis that altered post-synaptic glutamatergic transmission is related to deficits in learning and plasticity in this animal model.
authors.affiliation: Center of Excellence on Neurodegenerative Diseases and Department of Pharmacological Sciences, University of Milano, Milan, Italy. Fabrizio.Gardoni@unimi.it
authors.forename: F
authors.initials: F
authors.lastname: Gardoni
authors.forename: A
authors.initials: A
authors.lastname: Kamal
authors.forename: C
authors.initials: C
authors.lastname: Bellone
authors.forename: G J
authors.initials: GJ
authors.lastname: Biessels
authors.forename: G M J
authors.initials: GM
authors.lastname: Ramakers
authors.forename: F
authors.initials: F
authors.lastname: Cattabeni
authors.forename: W H
authors.initials: WH
authors.lastname: Gispent
authors.forename: M
authors.initials: M
authors.lastname: Di Luca
mesh_terms: D000818:Animals; D015153:Blotting, Western; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism; D002493:Central Nervous System Diseases / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D019706:Excitatory Postsynaptic Potentials / Q000502:physiology; D006624:Hippocampus / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D008297:Male; D009473:Neuronal Plasticity / Q000502:physiology; D009924:Organ Culture Techniques; D010766:Phosphorylation; D017966:Pyramidal Cells / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D016194:Receptors, N-Methyl-D-Aspartate / Q000032:analysis / Q000378:metabolism*
chemical_list: C120997:NR2A NMDA receptor; C121001:NR2B NMDA receptor; D016194:Receptors, N-Methyl-D-Aspartate; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases